Kathleen A Martin Selected Research

Cardiomegaly (Heart Hypertrophy)

1/2021	Correction for McMullen et al., "Deletion of Ribosomal S6 Kinases Does Not Attenuate Pathological, Physiological, or Insulin-Like Growth Factor 1 Receptor-Phosphoinositide 3-Kinase-Induced Cardiac Hypertrophy".
7/2004	Deletion of ribosomal S6 kinases does not attenuate pathological, physiological, or insulin-like growth factor 1 receptor-phosphoinositide 3-kinase-induced cardiac hypertrophy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kathleen A Martin Research Topics

Disease

8	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2007
7	Hyperplasia 01/2021 - 03/2004
5	Atherosclerosis 01/2017 - 04/2006
4	Thrombosis (Thrombus) 05/2015 - 04/2008
3	Diabetes Mellitus 12/2017 - 01/2012
2	Pathologic Constriction (Stenosis) 04/2022 - 01/2022
2	Neointima 01/2022 - 01/2019
2	Fibrosis (Cirrhosis) 12/2021 - 01/2019
2	Cardiomegaly (Heart Hypertrophy) 01/2021 - 07/2004
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2019 - 01/2012
2	Vascular Diseases (Vascular Disease) 12/2017 - 01/2011
2	Heart Failure 12/2017 - 01/2012
2	Hyperglycemia 05/2015 - 01/2012
2	Neoplasms (Cancer) 01/2014 - 03/2010
2	Hypertension (High Blood Pressure) 10/2012 - 01/2012
1	Aortic Valve Disease 04/2022
1	Vascular System Injuries 01/2022
1	Coronary Disease (Coronary Heart Disease) 01/2021
1	Blood Platelet Disorders (Thrombocytopathy) 01/2021
1	Arteriovenous Fistula 01/2019
1	Weight Loss (Weight Reduction) 01/2019
1	Weight Gain 01/2019
1	Reperfusion Injury 06/2018
1	Myocardial Ischemia (Ischemic Heart Diseases) 06/2018
1	Obesity 09/2015
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2015
1	Hypertrophy 04/2013
1	Williams Syndrome (Williams-Beuren Syndrome) 10/2012
1	Supravalvular Aortic Stenosis (Aortic Supravalvular Stenosis) 10/2012
1	Hyperlipidemias (Hyperlipidemia) 10/2012
1	Insulin Resistance 01/2012
1	Type 2 Diabetes Mellitus (MODY) 01/2012
1	Diabetes Complications 01/2012
1	Rheumatoid Arthritis 01/2011

Drug/Important Bio-Agent (IBA)

5	Epoprostenol (Prostacyclin)FDA LinkGeneric 01/2011 - 04/2006
3	Proteins (Proteins, Gene)FDA Link 04/2022 - 10/2012
3	Mechanistic Target of Rapamycin Complex 1IBA 12/2017 - 04/2013
3	Sirolimus (Rapamycin)FDA Link 12/2017 - 03/2004
3	Epoprostenol ReceptorsIBA 01/2009 - 01/2007
2	ElastinIBA 01/2022 - 10/2012
2	Insulin-Like PeptidesIBA 01/2021 - 07/2004
2	Phosphotransferases (Kinase)IBA 01/2021 - 07/2004
2	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2021 - 07/2004
2	ChromatinIBA 12/2017 - 01/2017
2	Pharmaceutical PreparationsIBA 09/2015 - 05/2015
2	EicosanoidsIBA 10/2012 - 01/2007
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2009 - 04/2008
1	NeuropilinsIBA 04/2022
1	Histones (Histone)IBA 01/2022
1	TransferasesIBA 01/2022
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2022
1	CC ChemokinesIBA 12/2021
1	LigandsIBA 12/2021
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 12/2021
1	Kruppel-Like Transcription Factors (Kruppel-Like Factors)IBA 12/2021
1	Becaplermin (PDGF-BB)FDA Link 01/2021
1	ThiazolidinedionesIBA 01/2021
1	Circular RNAIBA 01/2021
1	IntegrinsIBA 01/2021
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2021
1	Mitogen-Activated Protein KinasesIBA 01/2021
1	AnticoagulantsIBA 01/2021
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2021
1	Transcription Factor 7-Like 2 ProteinIBA 01/2019
1	Low Density Lipoprotein Receptor-Related Protein-1 (LDL-Receptor Related Protein)IBA 01/2019
1	salicylhydroxamic acid (SHAM)IBA 01/2019
1	CytokinesIBA 01/2019
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2019
1	MicroRNAs (MicroRNA)IBA 06/2018
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 12/2017
1	Protein Isoforms (Isoforms)IBA 12/2017
1	Transcription Factors (Transcription Factor)IBA 01/2017
1	LDL Receptors (LDL Receptor)IBA 01/2017
1	MelanocortinsIBA 09/2015
1	Dipeptidyl-Peptidase IV InhibitorsIBA 09/2015
1	Serotonin AgentsIBA 09/2015
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 09/2015
1	Lipase (Acid Lipase)FDA Link 09/2015
1	Glucagon-Like Peptide-1 ReceptorIBA 09/2015
1	Orlistat (Xenical)FDA Link 09/2015
1	Aldehyde Reductase (Aldose Reductase)IBA 05/2015
1	Messenger RNA (mRNA)IBA 05/2015
1	von Willebrand FactorIBA 05/2015
1	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2015
1	ResveratrolIBA 01/2014
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 04/2013
1	GTP-Binding Proteins (G-Protein)IBA 04/2013
1	CarbonIBA 10/2012
1	Essential Fatty AcidsIBA 10/2012
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 10/2012
1	Arachidonic Acid (Vitamin F)IBA 10/2012
1	Glucose (Dextrose)FDA LinkGeneric 01/2012
1	polyolIBA 01/2012
1	AdiponectinIBA 01/2012
1	Insulin (Novolin)FDA Link 01/2012

Therapy/Procedure

5	Therapeutics 01/2021 - 12/2008
2	Drug-Eluting Stents 01/2021 - 12/2017
1	Gastrectomy 01/2019
1	Ligation 01/2019
1	Drug Therapy (Chemotherapy) 09/2015